| First Author | Bezard E | Year | 1999 |
| Journal | Exp Neurol | Volume | 155 |
| Issue | 2 | Pages | 268-73 |
| PubMed ID | 10072302 | Mgi Jnum | J:53439 |
| Mgi Id | MGI:1332728 | Doi | 10.1006/exnr.1998.6995 |
| Citation | Bezard E, et al. (1999) Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter. Exp Neurol 155(2):268-73 |
| abstractText | MPTP has been shown to induce parkinsonism both in human and in nonhuman primates. The precise mechanism of dopaminergic cell death induced following MPTP treatment is still subject to intense debate. MPP+, which is the oxidation product of MPTP, is actively transported into presynaptic dopaminergic nerve terminals through the plasma membrane dopamine transporter (DAT). In this study, we used mice lacking the DAT by homologous recombination and demonstrated that the MPTP-induced dopaminergic cell loss is dependent on the presence of the DAT. For this we have used tyrosine hydroxylase immunoreactivity (TH- IR) labeling of dopamine cells of the substantia nigra compacta in wild- type, heterozygote, and homozygote mice that were given either saline or MPTP treatments (two ip injections of 30 mg/kg, 10 h apart). Our results show a significant loss of TH-IR in wild type (34.4%), less loss in heterozygotes (22.5%), and no loss in homozygote animals. Thus dopamine cell loss is related to levels of the DAT. These results shed light on the degenerative process of dopamine neurons and suggest that individual differences in developing Parkinson's disease in human may be related to differences of uptake through the DAT of a yet unidentified neurotoxin. Copyright 1999 Academic Press. |
